Replies to post #175908 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

It is a public statement, actionable by the SEC for misrepresentation, that the information in the paper reinforces the data developing in the trials.

It doesn't have to be "unique", but trail results so far indicate that 2-73 is better than anything on the market.

No one gets a benefit from Donepezil for three years.

[Investor2014]

Converging is better than diverging evidence, don’t you think?